Vikram Thermo (India) (BOM:530477) Beneish M-Score: 79.00 (As of Jun. 30, 2026)


BOM:530477 Vikram Thermo (India) Ltd BOM:530477
87 GF Score
Price ₹241.35
GF Value ₹181.95
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vikram Thermo (India) Beneish M-Score?

Vikram Thermo (India) BOM:530477 +4.89% 87 Beneish M-Score is 79.00 as of Jun. 30, 2026. GuruFocus rates BOM:530477 with a GF Score™ of 87/100 and a GF Value™ of ₹181.95 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 908 Drug Manufacturers companies, Vikram Thermo (India) ranks worse than 99.67% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 79 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Vikram Thermo (India)'s Beneish M-Score or its related term are showing as below:

BOM:530477' s Beneish M-Score Range Over the Past 10 Years
Min: -3.14   Med: -2.27   Max: 79
Current: 79

During the past 13 years, the highest Beneish M-Score of Vikram Thermo (India) was 79.00. The lowest was -3.14. And the median was -2.27.


Vikram Thermo (India) Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Vikram Thermo (India)'s Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vikram Thermo (India) Beneish M-Score Chart

Vikram Thermo (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.28 -2.12 -2.28 -3.14 79.00

Vikram Thermo (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.14 0.00 0.00 0.00 79.00

BOM:530477 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vikram Thermo (India)'s Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vikram Thermo (India) Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vikram Thermo (India)'s Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Vikram Thermo (India)'s Beneish M-Score falls into.


BOM:530477
87GF Score
Vikram Thermo (India) Ltd BOM:530477
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vikram Thermo (India) Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Vikram Thermo (India) for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8709+0.528 * 0.878+0.404 * 203.4832+0.892 * 1.0623+0.115 * 0.6229
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.069619-0.327 * 1.0039
=79.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹460 Mil.
Revenue was ₹1,341 Mil.
Gross Profit was ₹908 Mil.
Total Current Assets was ₹850 Mil.
Total Assets was ₹1,879 Mil.
Property, Plant and Equipment(Net PPE) was ₹574 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹30 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹258 Mil.
Long-Term Debt & Capital Lease Obligation was ₹30 Mil.
Net Income was ₹385 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹516 Mil.
Total Receivables was ₹497 Mil.
Revenue was ₹1,262 Mil.
Gross Profit was ₹750 Mil.
Total Current Assets was ₹628 Mil.
Total Assets was ₹1,459 Mil.
Property, Plant and Equipment(Net PPE) was ₹830 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹26 Mil.
Selling, General, & Admin. Expense(SGA) was ₹70 Mil.
Total Current Liabilities was ₹201 Mil.
Long-Term Debt & Capital Lease Obligation was ₹22 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(459.67 / 1340.977) / (496.863 / 1262.306)
=0.342787 / 0.393615
=0.8709

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(750.196 / 1262.306) / (907.694 / 1340.977)
=0.594306 / 0.67689
=0.878

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (850.416 + 574.425) / 1879.088) / (1 - (627.628 + 829.551) / 1458.912)
=0.241738 / 0.001188
=203.4832

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1340.977 / 1262.306
=1.0623

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(26.183 / (26.183 + 829.551)) / (29.674 / (29.674 + 574.425))
=0.030597 / 0.049121
=0.6229

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 1340.977) / (69.606 / 1262.306)
=0 / 0.055142
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((30.008 + 257.763) / 1879.088) / ((21.883 + 200.683) / 1458.912)
=0.153144 / 0.152556
=1.0039

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(384.985 - 0 - 515.805) / 1879.088
=-0.069619

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Vikram Thermo (India) has a M-score of 79.00 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 79.00 mean?
Vikram Thermo (India) (BOM:530477) has a Beneish M-Score of 79.00 as of Jun. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Vikram Thermo (India) and its competitors. According to the industry distribution chart, Vikram Thermo (India) ranks #905 out of 908 companies in the Drug Manufacturers industry, placing it in the top 99.7%.
Is Vikram Thermo (India)'s Beneish M-Score too high?
Vikram Thermo (India)'s current Beneish M-Score is 79.00. Based on the distribution chart, Vikram Thermo (India) ranks #905 out of 908 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vikram Thermo (India) has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vikram Thermo (India)'s Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vikram Thermo (India) ranks #905 out of 908 companies for Beneish M-Score. This places Vikram Thermo (India) in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Vikram Thermo (India) and its competitors. Vikram Thermo (India)'s current Beneish M-Score is 79.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vikram Thermo (India) stock overvalued right now?
Based on GuruFocus' analysis, Vikram Thermo (India) (BOM:530477) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹181.95, compared to a current price of ₹241.35 — trading 32.6% above its estimated fair value. The current Beneish M-Score is 79.00. Vikram Thermo (India)'s overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Vikram Thermo (India) (BOM:530477), the current Beneish M-Score is 79.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vikram Thermo (India) (BOM:530477) Overvalued in 2026?

Based on GuruFocus' analysis, Vikram Thermo (India) stock appears to be overvalued. The current stock price of ₹241.35 is trading 32.6% above its estimated GF Value™ of ₹181.95. GuruFocus considers Vikram Thermo (India) to be Significantly Overvalued.

Key valuation signals for BOM:530477:

  • Beneish M-Score: 79.00
  • GF Value™: ₹181.95 vs. price of ₹241.35 (32.6% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the BOM:530477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vikram Thermo (India) Business Description

Address Science City Road, A/704-714, The Capital, Ahmedabad, GJ, IND, 380060
Vikram Thermo (India) Ltd is engaged in the manufacturing and selling of basic pharma co-polymer Drug Coat, Diphenyl Oxide, Aquapol line of cosmetic polymers, and Apion line of cross-linked polymers. Through its products, the company provides a complete solution for various applications in the solid oral dosage coating segment with complementary technical support. It operates in a single segment, Chemicals. Geographically, the company generates maximum revenue from its business in India, followed by the Rest of the world.
87GF Score

Get the complete analysis for BOM:530477

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹241.35
Price
₹181.95
GF Value